Keymed Biosciences Inc. (HKG: 2162)
Hong Kong
· Delayed Price · Currency is HKD
32.60
-1.05 (-3.12%)
Dec 19, 2024, 2:02 PM HKT
Keymed Biosciences Revenue
Keymed Biosciences had revenue of 54.68M CNY in the half year ending June 30, 2024, a decrease of -45.32%. This brings the company's revenue in the last twelve months to 81.65M, down -75.04% year-over-year. In the year 2023, Keymed Biosciences had annual revenue of 354.10M with 253.87% growth.
Revenue (ttm)
81.65M CNY
Revenue Growth
-75.04%
P/S Ratio
97.17
Revenue / Employee
88.08K CNY
Employees
927
Market Cap
8.98B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 354.10M | 254.03M | 253.87% |
Dec 31, 2022 | 100.06M | -10.21M | -9.26% |
Dec 31, 2021 | 110.27M | - | - |
Dec 31, 2020 | - | - | - |
Dec 31, 2019 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition